PHARMACYTE BIOTECH, INC. Stock Repurchased During Period, Value
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- PHARMACYTE BIOTECH, INC. stock repurchased during period, value for the quarter ending 2025-01-31 was $227.28K, a 43.84% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, value for the quarter ending 2024-10-31 was $1.42M, a 750.86% increase year-over-year.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, value for the quarter ending 2024-07-31 was $749.60K, a 97.19% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, value for the quarter ending 2024-01-31 was $404.72K, a 89.29% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, value for fiscal 2025 was $2.57M, a 90.98% decline from fiscal 2024.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, value for fiscal 2024 was $28.48M, a 110.02% increase from fiscal 2023.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, value for fiscal 2023 was $13.56M.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, value for fiscal 2015 was $3.34M.
| Period end | Stock Repurchased During Period, Value 3 month | Stock Repurchased During Period, Value 12 month |
|---|---|---|
| 2025-04-30 | $2.57M 10-K · filed 2026-07-29 | |
| 2025-01-31 | $227.28K 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $1.42M 10-Q · filed 2026-03-17 | |
| 2024-07-31 | $749.60K 10-Q · filed 2026-03-17 | |
| 2024-04-30 | $28.48M 10-K · filed 2025-08-11 | |
| 2024-01-31 | $404.72K 10-Q · filed 2024-03-18 | |
| 2023-10-31 | $166.60K 10-Q · filed 2024-03-18 | |
| 2023-07-31 | $26.72M 10-Q · filed 2025-03-17 | |
| 2023-04-30 | $13.56M 10-K · filed 2024-08-13 | |
| 2023-01-31 | $3.78M 10-Q · filed 2024-03-18 | |
| 2022-10-31 | $3.39M 10-Q · filed 2024-03-18 | |
| 2022-07-31 | $2.09M 10-Q · filed 2024-03-18 | |
| 2020-01-31 | $450.00K 10-Q · filed 2021-03-12 | |
| 2015-04-30 | $3.34M 10-K · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |